Cure My Disease

Don't miss your cure!

 Log in / Sign up

Radiofrequency device tested as Add-On for stubborn back pain

NCT ID NCT07825298

Symptom relief Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Researchers at Cairo University are testing whether adding TECAR therapy, a device that sends radiofrequency energy into tissues, helps adults with chronic low back pain more than physiotherapy alone. The trial enrolls 80 people who have had low back pain for more than three months. Participants receive 12 sessions over four weeks of either physiotherapy plus TECAR or physiotherapy plus a sham device, and researchers measure pain, disability, core endurance, back movement, and exercise capacity before and after treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
TECAR therapy, a device that delivers radiofrequency energy to tissues
What this could lead to
If it works, TECAR therapy could become an add-on option for people whose chronic low back pain does not improve with physiotherapy alone.
What could go wrong
This is a small, single-center study of 80 people, so any benefit may be modest or may not hold up in larger trials. TECAR is not suitable for people with pacemakers or during pregnancy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * localised pain between the 12th rib and the gluteal fold * low back pain for more than three months Exclusion Criteria: * neuropathic pain extending along the lower limb * previous spine surgery * history of spine trauma or fracture, * implanted pacemakers. * pregnancy * cancer * systemic musculoskeletal diseases, * neurodegenerative diseases. * epilepsy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low back pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Back Pain Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Low back pain Tecar therapy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Batterjee Medical college

    Jeddah, 21442, Saudi Arabia

More trials for these conditions

Other studies related to the condition(s) this trial covers.